
Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience
8°C · 59% rain
Rain likely — worth a coat for the walk in.
Ask AI: is it for me?
Similar events
View allAbout This Event
A panel discussion titled 'Remedicalising the Psychedelic Experience' will be held at New College in Oxford on 19 November 2026. Led by Prof Guy Goodwin, the discussion will focus on breakthrough trials of psilocybin for depression and the clinical research conducted by Compass Pathways. The event aims to explore the potential of psychedelics as a treatment for mood disorders.
Join us for a panel discussion on breakthrough trials of psilocybin for depression, led by Prof Guy Goodwin, CMO at Compass Pathways.
This panel explores the pioneering clinical research conducted by Compass Pathways in Oxford into the use of psychedelics as a treatment for depression. Its lead synthetic psilocybin compound, COMP360, is currently undergoing FDA review, placing the company at the forefront of efforts to secure regulatory approval for psychedelic-assisted therapies. The Oxford Psychedelic and Psychology Societies are thrilled to host four research scientists from Compass Pathways:
Guy Goodwin is CMO, Compass Pathways, and Emeritus Professor of Psychiatry at the University of Oxford, UK. His research interests are the treatment of mood disorder and the potential to improve treatment using new technology and new drugs, notably the psychedelics. He is a Fellow of the American College of Neuropsychopharmacology, and has previously held the position of President of the British Association for Psychopharmacology and the European College of Neuropsychopharmacology (ECNP).
Dr Katharine Smith is an Honorary Consultant Psychiatrist at the University of Oxford Department of Psychiatry and at Oxford Health NHS Foundation Trust. She is Clinical Lead at the NIHR Oxford Health Clinical Research Facility and was recently the Principal Investigator at the Oxford site for the COMP006 study investigating psilocybin in treatment resistant depression.
Dr Niall McGowan is a Principal Clinical Research Scientist with expertise in clinical trial design, development, and scientific strategy. He specialises in translating complex scientific and clinical questions into rigorous study designs and development strategies. At Compass Pathways, he leads the clinical development of psilocybin for post-traumatic stress disorder (PTSD). Prior to joining Compass Pathways, Niall was a post-doctoral research associate at Oxford's Department of Psychiatry where he researched personality disorders and affective disorders.
Ella Williams is a DPhil candidate at the University of Oxford, where her research investigates the neuropsychological mechanisms through which rapid-acting antidepressants exert their effects. As part of her doctoral work, she is establishing the first experimental medicine study in humans using psilocybin at the University of Oxford. She is currently working as a Clinical Research Scientist at Compass Pathways, where she contributes to the clinical development of psilocybin for treatment-resistant depression.
Description supplied by the event organiser.
Staying overnight?
Hotels within walking distance of New College.
Ad · Stay22 affiliate link
Similar Events in Oxford
View all →
Mon, 7 Dec 2026
The Science of Autism & Women: Unseen and unheard
Said Business School
From £13.50

Thu, 19 Nov 2026
Marketing Camp Outpost // OXFORD // Developing your brand's AI policy
The White Rabbit
Free Entry

Mon, 23 Nov 2026
Careers at the United Nations: Panel & Networking
Manor Road Building, Lecture Theatre
Free Entry

Wed, 6 Jan 2027
Wild LIVE - Digging deeper: is soil our most valuable asset?
Old Fire Station
£5

Tue, 12 Jan 2027
Understanding & Responding To Christian Nationalism
Church House Oxford
Free Entry

Fri, 19 Feb 2027
Compassion in Buddhism: A panel discussion
The Stephen A. Schwarzman Centre for the Humanities
Free Entry
Frequently asked questions
Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience takes place on Thursday, 19 November 2026 at 19:30.
Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience is held at New College in Oxford (Holywell Street, Oxford, OX1 3BN).
Tickets for Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience are priced at £3.96. Live prices and availability are shown on Eventbrite.
The forecast for Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience is Drizzle · 8°C. Rain likely — worth a coat for the walk in.
Yes — hotels within walking distance of New College can be compared using the accommodation search further down this page.
Tickets for Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience can be booked via Eventbrite using the "Check Tickets & Live Prices" button on this page, which opens the official booking site in a new tab.
Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience
Editorial summaryAbout this event
A panel discussion titled 'Remedicalising the Psychedelic Experience' will be held at New College in Oxford on 19 November 2026. Led by Prof Guy Goodwin, the discussion will focus on breakthrough trials of psilocybin for depression and the clinical research conducted by Compass Pathways. The event aims to explore the potential of psychedelics as a treatment for mood disorders.
This summary was automatically generated from event data sourced from official ticketing providers.
Join us for a panel discussion on breakthrough trials of psilocybin for depression, led by Prof Guy Goodwin, CMO at Compass Pathways.
This panel explores the pioneering clinical research conducted by Compass Pathways in Oxford into the use of psychedelics as a treatment for depression. Its lead synthetic psilocybin compound, COMP360, is currently undergoing FDA review, placing the company at the forefront of efforts to secure regulatory approval for psychedelic-assisted therapies. The Oxford Psychedelic and Psychology Societies are thrilled to host four research scientists from Compass Pathways:
Guy Goodwin is CMO, Compass Pathways, and Emeritus Professor of Psychiatry at the University of Oxford, UK. His research interests are the treatment of mood disorder and the potential to improve treatment using new technology and new drugs, notably the psychedelics. He is a Fellow of the American College of Neuropsychopharmacology, and has previously held the position of President of the British Association for Psychopharmacology and the European College of Neuropsychopharmacology (ECNP).
Dr Katharine Smith is an Honorary Consultant Psychiatrist at the University of Oxford Department of Psychiatry and at Oxford Health NHS Foundation Trust. She is Clinical Lead at the NIHR Oxford Health Clinical Research Facility and was recently the Principal Investigator at the Oxford site for the COMP006 study investigating psilocybin in treatment resistant depression.
Dr Niall McGowan is a Principal Clinical Research Scientist with expertise in clinical trial design, development, and scientific strategy. He specialises in translating complex scientific and clinical questions into rigorous study designs and development strategies. At Compass Pathways, he leads the clinical development of psilocybin for post-traumatic stress disorder (PTSD). Prior to joining Compass Pathways, Niall was a post-doctoral research associate at Oxford's Department of Psychiatry where he researched personality disorders and affective disorders.
Ella Williams is a DPhil candidate at the University of Oxford, where her research investigates the neuropsychological mechanisms through which rapid-acting antidepressants exert their effects. As part of her doctoral work, she is establishing the first experimental medicine study in humans using psilocybin at the University of Oxford. She is currently working as a Clinical Research Scientist at Compass Pathways, where she contributes to the clinical development of psilocybin for treatment-resistant depression.
Description supplied by the event organiser.
StayStaying overnight?
Hotels within walking distance of New College. Searching near Holywell Street, Oxford, OX1 3BN; check-in Thursday, 19 November 2026.
Ad · Stay22 affiliate link
WhereNew College
Holywell Street, Oxford, OX1 3BN
Before you goFrequently asked questions
When is Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience?
Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience takes place on Thursday, 19 November 2026 at 19:30.
Where is Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience taking place?
Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience is held at New College in Oxford (Holywell Street, Oxford, OX1 3BN).
How much are tickets for Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience?
Tickets for Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience are priced at £3.96. Live prices and availability are shown on Eventbrite.
What will the weather be like at Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience?
The forecast for Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience is Drizzle · 8°C. Rain likely — worth a coat for the walk in.
Is there anywhere to stay near Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience?
Yes — hotels within walking distance of New College can be compared using the accommodation search further down this page.
How do I get tickets for Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience?
Tickets for Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience can be booked via Eventbrite using the "Check Tickets & Live Prices" button on this page, which opens the official booking site in a new tab.
Price
£3.96
Date
Time
Weather
feels like 5°C · chance of rain 59% · wind 8 km/h
Venue
Holywell Street, Oxford, OX1 3BN
Secure checkout on Eventbrite — opens in a new tab
Ask AI: is it for me?
EventsList lists 213,000+ events across the UK. Tickets are sold by the venue or its authorised sellers, never by us.
Not this one?Similar events in Oxford
View allMore things to do in Oxford
- Paranormal Night with Dr Ciaran O'KeeffeSaturday, 5 December 2026
- Adam Grant: The Secret to Successful ConnectionsWednesday, 9 December 2026
- Oxford Water Network Michaelmas TermTuesday, 24 November 2026
- New Frontiers: The Science & Technology of Space ExplorationWednesday, 2 December 2026
- Richard House DISHONEST DAYSWednesday, 20 January 2027
- Fantasy series: Dr Clare Mulley 'From Psychopomp to Pop Cultural Fantasy'Thursday, 19 November 2026
- Doireann Ní Ghríofa SAID THE DEADThursday, 26 November 2026
- When Health Divides Us: Trust, Misinformation and CommunityWednesday, 24 February 2027
- Distinguished Speaker Seminar: Alex SchultzTuesday, 24 November 2026
- Against Malaria Foundation: Exploring Impact, Altruism and AccountabilityThursday, 19 November 2026
- Sustainability Educators Growing Together – Sharing Our Practice, Progress, and PossibilitiesThursday, 19 November 2026
- Sharing and Celebrating: A Talking Time eventThursday, 19 November 2026
- Oxford Sustainable Law Programme Guest Seminar - Dr. Dan ShugarThursday, 19 November 2026
- Juanita Hughes afternoon talkThursday, 19 November 2026






